|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:TFRC-BLOC1S5 (FusionGDB2 ID:89768) |
Fusion Gene Summary for TFRC-BLOC1S5 |
Fusion gene summary |
Fusion gene information | Fusion gene name: TFRC-BLOC1S5 | Fusion gene ID: 89768 | Hgene | Tgene | Gene symbol | TFRC | BLOC1S5 | Gene ID | 7037 | 63915 |
Gene name | transferrin receptor | biogenesis of lysosomal organelles complex 1 subunit 5 | |
Synonyms | CD71|IMD46|T9|TFR|TFR1|TR|TRFR|p90 | BLOS5|MU|MUTED | |
Cytomap | 3q29 | 6p24.3 | |
Type of gene | protein-coding | protein-coding | |
Description | transferrin receptor protein 1 | biogenesis of lysosome-related organelles complex 1 subunit 5BLOC-1 subunit 5biogenesis of lysosomal organelles complex-1, subunit 5, mutedmuted homologprotein Muted homolog | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | Q8TDH9 | |
Ensembl transtripts involved in fusion gene | ENST00000420415, ENST00000360110, ENST00000540528, ENST00000392396, ENST00000535031, ENST00000465288, | ENST00000397457, ENST00000543936, ENST00000475998, | |
Fusion gene scores | * DoF score | 11 X 12 X 8=1056 | 3 X 2 X 3=18 |
# samples | 15 | 3 | |
** MAII score | log2(15/1056*10)=-2.81557542886257 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: TFRC [Title/Abstract] AND BLOC1S5 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | TFRC(195803935)-BLOC1S5(8041501), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. | TFRC-BLOC1S5 seems lost the major protein functional domain in Hgene partner, which is a CGC due to the frame-shifted ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | TFRC | GO:0006826 | iron ion transport | 7556058 |
Hgene | TFRC | GO:0030890 | positive regulation of B cell proliferation | 26642240 |
Hgene | TFRC | GO:0031623 | receptor internalization | 26642240 |
Hgene | TFRC | GO:0033572 | transferrin transport | 26642240 |
Hgene | TFRC | GO:0035690 | cellular response to drug | 16254249 |
Hgene | TFRC | GO:0042102 | positive regulation of T cell proliferation | 26642240 |
Hgene | TFRC | GO:0045830 | positive regulation of isotype switching | 26642240 |
Tgene | BLOC1S5 | GO:0032402 | melanosome transport | 17182842 |
Tgene | BLOC1S5 | GO:0035646 | endosome to melanosome transport | 17182842 |
Tgene | BLOC1S5 | GO:0050942 | positive regulation of pigment cell differentiation | 17182842 |
Fusion gene breakpoints across TFRC (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across BLOC1S5 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | PRAD | TCGA-G9-A9S7-01A | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
ChimerDB4 | PRAD | TCGA-G9-A9S7 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
Top |
Fusion Gene ORF analysis for TFRC-BLOC1S5 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000420415 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5UTR-3CDS | ENST00000420415 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5UTR-intron | ENST00000420415 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
In-frame | ENST00000360110 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
In-frame | ENST00000360110 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5CDS-intron | ENST00000360110 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
In-frame | ENST00000540528 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
In-frame | ENST00000540528 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5CDS-intron | ENST00000540528 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
Frame-shift | ENST00000392396 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
Frame-shift | ENST00000392396 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5CDS-intron | ENST00000392396 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5UTR-3CDS | ENST00000535031 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5UTR-3CDS | ENST00000535031 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
5UTR-intron | ENST00000535031 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
intron-3CDS | ENST00000465288 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
intron-3CDS | ENST00000465288 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
intron-intron | ENST00000465288 | ENST00000475998 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000360110 | TFRC | chr3 | 195803935 | - | ENST00000397457 | BLOC1S5 | chr6 | 8041501 | - | 2657 | 206 | 170 | 574 | 134 |
ENST00000360110 | TFRC | chr3 | 195803935 | - | ENST00000543936 | BLOC1S5 | chr6 | 8041501 | - | 1161 | 206 | 170 | 574 | 134 |
ENST00000540528 | TFRC | chr3 | 195803935 | - | ENST00000397457 | BLOC1S5 | chr6 | 8041501 | - | 2558 | 107 | 71 | 475 | 134 |
ENST00000540528 | TFRC | chr3 | 195803935 | - | ENST00000543936 | BLOC1S5 | chr6 | 8041501 | - | 1062 | 107 | 71 | 475 | 134 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000360110 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - | 0.007038389 | 0.9929616 |
ENST00000360110 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - | 0.007699435 | 0.9923005 |
ENST00000540528 | ENST00000397457 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - | 0.018399179 | 0.98160076 |
ENST00000540528 | ENST00000543936 | TFRC | chr3 | 195803935 | - | BLOC1S5 | chr6 | 8041501 | - | 0.009796648 | 0.9902034 |
Top |
Fusion Genomic Features for TFRC-BLOC1S5 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for TFRC-BLOC1S5 |
Go to FGviewer for the breakpoints of chr3:195803935-chr6:8041501 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | BLOC1S5 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Component of the BLOC-1 complex, a complex that is required for normal biogenesis of lysosome-related organelles (LRO), such as platelet dense granules and melanosomes. In concert with the AP-3 complex, the BLOC-1 complex is required to target membrane protein cargos into vesicles assembled at cell bodies for delivery into neurites and nerve terminals. The BLOC-1 complex, in association with SNARE proteins, is also proposed to be involved in neurite extension. Plays a role in intracellular vesicle trafficking. {ECO:0000269|PubMed:17182842}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | BLOC1S5 | chr3:195803935 | chr6:8041501 | ENST00000397457 | 1 | 5 | 154_186 | 65.0 | 188.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | BLOC1S5 | chr3:195803935 | chr6:8041501 | ENST00000543936 | 2 | 6 | 154_186 | 1.0 | 124.0 | Coiled coil | Ontology_term=ECO:0000255 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 223_313 | 12.0 | 761.0 | Domain | Note=PA |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 223_313 | 12.0 | 761.0 | Domain | Note=PA |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 58_61 | 12.0 | 761.0 | Motif | Stop-transfer sequence |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 646_648 | 12.0 | 761.0 | Motif | Note=Cell attachment site%3B required for binding to transferrin |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 58_61 | 12.0 | 761.0 | Motif | Stop-transfer sequence |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 646_648 | 12.0 | 761.0 | Motif | Note=Cell attachment site%3B required for binding to transferrin |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 569_760 | 12.0 | 761.0 | Region | Note=Ligand-binding |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 569_760 | 12.0 | 761.0 | Region | Note=Ligand-binding |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 89_760 | 12.0 | 761.0 | Topological domain | Extracellular |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 89_760 | 12.0 | 761.0 | Topological domain | Extracellular |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000360110 | - | 2 | 19 | 68_88 | 12.0 | 761.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Hgene | TFRC | chr3:195803935 | chr6:8041501 | ENST00000392396 | - | 2 | 19 | 68_88 | 12.0 | 761.0 | Transmembrane | Helical%3B Signal-anchor for type II membrane protein |
Top |
Fusion Gene Sequence for TFRC-BLOC1S5 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000360110_ENST00000397457_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(transcript)=2657nt_BP=206nt CTCGCGAGCGTACGTGCCTCAGGAAGTGACGCACAGCCCCCCTGGGGGCCGGGGGCGGGGCCAGGCTATAAACCGCCGGTTAGGGGCCGC CATCCCCTCAGAGCGTCGGGATATCGGGTGGCGGCTCGGGACGGAGGACGCGCTAGTGTTCTTCTGTGTGGCAGTTCAGAATGATGGATC AAGCTAGATCAGCATTCTCTAACTTGGAAAAACGTGGTCTTCGAGAAATGCGAGTTCTTGAAAATTTGAAGAACATGATCCATGAAACAA ATGAACATACTCTTCCCAAATGTAGAGACACAATGCGGGACAGCCTCAGCCAGGTTCTCCAGAGATTGCAAGCAGCTAATGACTCAGTCT GTAGACTCCAACAGAGGGAACAGGAACGAAAAAAGATTCATAGTGACCACTTAGTAGCTAGTGAGAAACAGCATATGCTCCAGTGGGACA ACTTCATGAAGGAGCAACCCAACAAAAGGGCTGAAGTGGATGAAGAGCACAGAAAAGCCATGGAAAGGCTTAAAGAACAATATGCTGAGA TGGAGAAGGACCTAGCGAAATTTTCAACCTTTTAAGAACTTGAACCACAACAATCACAAACTAATGAGAAGATGTTCACCTCTCTCCTGA AAACTATTCCCACCAGACCGTTTAGCCTCTGCTTCAAGCTTAGCAATATATTCAGTGGCACTCTTATATCAGAAGAAAGAAGTTTCTACT GGCATTCTGATTGGATATTTAAAGAAGGGTGCCACATTTTTCCAGCTTTAAGTGCCTATATATGATTATTTGAATGAAGAGGAGTAGGAA GGAAAATGGAATCAATATACTCTTTGTTAGTCAGAATTGATCATCTTTTCCATTGATTAGCTCAGAGAACTGTAGGTATAGACTTCTTAG AAAGATAATTTCATTCATTTCTATACAGGGTTAACAATAGTTTATTATTGTGGCTTAATGGGAAGGTATAGAAGCTACCTGTCATAGCCT CCTTGGCTGTTGGAAGGATGTATAAAGTGTTACTGCATGAGTAATGTAGACAAAAAAAAAAGCCAGCTGTCCTTGGAGCAGAGATCACAT TTCAGAGAGGTGAGAGTGAACACATTGTCTCTGCTGTGGCAAAGATGGCCACGCTGGTGTTTGAGCTGCCTCTTGGGAAGCGTTGCATAT TTTACAGTGCAGCATAATGCCATGGGCTTCCGTGGATGGGAAGACACATGTTAAGTTTTGTGGCCTTCCAGCACTTACTATTTTCAGCTT TTTAAAGCATGCTTAGAAGGAAAAGCTTACCAAAAATATATTTTGACATTTAGTTTTTCCAAGAGCTATAATCTTGCCCATAGTATTTAC CTCATTTTTGTGTCTGTTTTGCTGTGGGTAAGCTTTATAAGATAAATAATGTCTATACATGTTTCGACTGTTTAATGAGTAATCAACAAA ATCTGCCAGAGAGTCCCTCTGGAACCATATAAAGTTCCTGGCTTTGAATGAACCAGAAGTGTTTGCCCACACAGCAAATGGTCCATGTTA AATGTAAATCCTTTTTAGTGTTAATGTCTGTTCTCATAAGCAGGTATATTATGATGAAACATGTACCAGTTCTGTCATCACTGTGATCTT TAAAAACCTGCATTTAACAGTCTAATTTGAGGCTGGGTGCAGTGGCTCACACCTGTAATCTCAACACTTTGGGAGGCCGAGGCAGGCGGA TCATTTGAAGTCAGGAGTTCAAGCCTAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCCCGGCATGTTGG TGCACGCTTGTAATCCCAGCTACTCAGGAGTCTGAGGCACGAGAATCACCTGAACTCAGGAGGCGGAGGTTGCGGTGAGCTGAGATGGCA CCACTGCACTCCAGCTTGGGTGACAGAGTGAGACTCCATCTCAACAAAAAAAAAATCTAACTGAAGAACTAAGTTGATTTTTTATTTGCC ATAAACCAAGCAAAAGTAAATGCAATAATTTCGAGATTTATGGTAAACAAATTTGAGGTATGGATAAATCTTTCACATATTTTTTATTGC TCTTTAGTAAAGAAAGGCACAAGAAAGAAAATATCCAGCTCTCTTGTGTTATCTCAGTGTGGCGACTGCAGAAAATTGACAATGCCTGCC TGTGTAAATGTATGGCTTACTGTCAAAGCTTCATTCTTGGCTGCATGTTGAAAATGTGATTAAAGTTAATAGAGGAGATGAAATAAGTAT TTGAGATTTTTTTCAATAACACTGAACTTCTGCCAACTTTCTCTATCCGCTACTGTAGGCTTGACAGGCTCATCAATCATTTGCTGGTAC CTGGACTAAAAAGCGCACTTGCTGACACCAAGGCATGTTGGAATTTTCTTAATTCAGTGGATGGAAAAAGAAATACTTCCAAAAATATCC CACACATGAAAAGGGAGGGGAGCCTTAAATGAAAATTCCCTTTGTACCGTAGACACTTTTTGGAATGCGATTAATTGCCAACACATCATT GAACGAATGCTGTAACCAAGAAATTAAGATTGTGTGTGTGAAGGGAATATATTCTTAACTGTGGCTACCCAACTTGTATAGCAAAGATTT >In-frame_ENST00000360110_ENST00000397457_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(amino acids)=134AA_start in transcript=170_stop in transcript=574 MMDQARSAFSNLEKRGLREMRVLENLKNMIHETNEHTLPKCRDTMRDSLSQVLQRLQAANDSVCRLQQREQERKKIHSDHLVASEKQHML -------------------------------------------------------------- >In-frame_ENST00000360110_ENST00000543936_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(transcript)=1161nt_BP=206nt CTCGCGAGCGTACGTGCCTCAGGAAGTGACGCACAGCCCCCCTGGGGGCCGGGGGCGGGGCCAGGCTATAAACCGCCGGTTAGGGGCCGC CATCCCCTCAGAGCGTCGGGATATCGGGTGGCGGCTCGGGACGGAGGACGCGCTAGTGTTCTTCTGTGTGGCAGTTCAGAATGATGGATC AAGCTAGATCAGCATTCTCTAACTTGGAAAAACGTGGTCTTCGAGAAATGCGAGTTCTTGAAAATTTGAAGAACATGATCCATGAAACAA ATGAACATACTCTTCCCAAATGTAGAGACACAATGCGGGACAGCCTCAGCCAGGTTCTCCAGAGATTGCAAGCAGCTAATGACTCAGTCT GTAGACTCCAACAGAGGGAACAGGAACGAAAAAAGATTCATAGTGACCACTTAGTAGCTAGTGAGAAACAGCATATGCTCCAGTGGGACA ACTTCATGAAGGAGCAACCCAACAAAAGGGCTGAAGTGGATGAAGAGCACAGAAAAGCCATGGAAAGGCTTAAAGAACAATATGCTGAGA TGGAGAAGGACCTAGCGAAATTTTCAACCTTTTAAGAACTTGAACCACAACAATCACAAACTAATGAGAAGATGTTCACCTCTCTCCTGA AAACTATTCCCACCAGACCGTTTAGCCTCTGCTTCAAGCTTAGCAATATATTCAGTGGCACTCTTATATCAGAAGAAAGAAGTTTCTACT GGCATTCTGATTGGATATTTAAAGAAGGGTGCCACATTTTTCCAGCTTTAAGTGCCTATATATGATTATTTGAATGAAGAGGAGTAGGAA GGAAAATGGAATCAATATACTCTTTGTTAGTCAGAATTGATCATCTTTTCCATTGATTAGCTCAGAGAACTGTAGGTATAGACTTCTTAG AAAGATAATTTCATTCATTTCTATACAGGGTTAACAATAGTTTATTATTGTGGCTTAATGGGAAGGTATAGAAGCTACCTGTCATAGCCT CCTTGGCTGTTGGAAGGATGTATAAAGTGTTACTGCATGAGTAATGTAGACAAAAAAAAAAGCCAGCTGTCCTTGGAGCAGAGATCACAT >In-frame_ENST00000360110_ENST00000543936_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(amino acids)=134AA_start in transcript=170_stop in transcript=574 MMDQARSAFSNLEKRGLREMRVLENLKNMIHETNEHTLPKCRDTMRDSLSQVLQRLQAANDSVCRLQQREQERKKIHSDHLVASEKQHML -------------------------------------------------------------- >In-frame_ENST00000540528_ENST00000397457_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(transcript)=2558nt_BP=107nt AGAGCGTCGGGATATCGGGTGGCGGCTCGGGACGGAGGACGCGCTAGTGTTCTTCTGTGTGGCAGTTCAGAATGATGGATCAAGCTAGAT CAGCATTCTCTAACTTGGAAAAACGTGGTCTTCGAGAAATGCGAGTTCTTGAAAATTTGAAGAACATGATCCATGAAACAAATGAACATA CTCTTCCCAAATGTAGAGACACAATGCGGGACAGCCTCAGCCAGGTTCTCCAGAGATTGCAAGCAGCTAATGACTCAGTCTGTAGACTCC AACAGAGGGAACAGGAACGAAAAAAGATTCATAGTGACCACTTAGTAGCTAGTGAGAAACAGCATATGCTCCAGTGGGACAACTTCATGA AGGAGCAACCCAACAAAAGGGCTGAAGTGGATGAAGAGCACAGAAAAGCCATGGAAAGGCTTAAAGAACAATATGCTGAGATGGAGAAGG ACCTAGCGAAATTTTCAACCTTTTAAGAACTTGAACCACAACAATCACAAACTAATGAGAAGATGTTCACCTCTCTCCTGAAAACTATTC CCACCAGACCGTTTAGCCTCTGCTTCAAGCTTAGCAATATATTCAGTGGCACTCTTATATCAGAAGAAAGAAGTTTCTACTGGCATTCTG ATTGGATATTTAAAGAAGGGTGCCACATTTTTCCAGCTTTAAGTGCCTATATATGATTATTTGAATGAAGAGGAGTAGGAAGGAAAATGG AATCAATATACTCTTTGTTAGTCAGAATTGATCATCTTTTCCATTGATTAGCTCAGAGAACTGTAGGTATAGACTTCTTAGAAAGATAAT TTCATTCATTTCTATACAGGGTTAACAATAGTTTATTATTGTGGCTTAATGGGAAGGTATAGAAGCTACCTGTCATAGCCTCCTTGGCTG TTGGAAGGATGTATAAAGTGTTACTGCATGAGTAATGTAGACAAAAAAAAAAGCCAGCTGTCCTTGGAGCAGAGATCACATTTCAGAGAG GTGAGAGTGAACACATTGTCTCTGCTGTGGCAAAGATGGCCACGCTGGTGTTTGAGCTGCCTCTTGGGAAGCGTTGCATATTTTACAGTG CAGCATAATGCCATGGGCTTCCGTGGATGGGAAGACACATGTTAAGTTTTGTGGCCTTCCAGCACTTACTATTTTCAGCTTTTTAAAGCA TGCTTAGAAGGAAAAGCTTACCAAAAATATATTTTGACATTTAGTTTTTCCAAGAGCTATAATCTTGCCCATAGTATTTACCTCATTTTT GTGTCTGTTTTGCTGTGGGTAAGCTTTATAAGATAAATAATGTCTATACATGTTTCGACTGTTTAATGAGTAATCAACAAAATCTGCCAG AGAGTCCCTCTGGAACCATATAAAGTTCCTGGCTTTGAATGAACCAGAAGTGTTTGCCCACACAGCAAATGGTCCATGTTAAATGTAAAT CCTTTTTAGTGTTAATGTCTGTTCTCATAAGCAGGTATATTATGATGAAACATGTACCAGTTCTGTCATCACTGTGATCTTTAAAAACCT GCATTTAACAGTCTAATTTGAGGCTGGGTGCAGTGGCTCACACCTGTAATCTCAACACTTTGGGAGGCCGAGGCAGGCGGATCATTTGAA GTCAGGAGTTCAAGCCTAGCCTGGCCAACATGGTGAAACCCCGTCTCTACTAAAAATACAAAAATTAGCCCGGCATGTTGGTGCACGCTT GTAATCCCAGCTACTCAGGAGTCTGAGGCACGAGAATCACCTGAACTCAGGAGGCGGAGGTTGCGGTGAGCTGAGATGGCACCACTGCAC TCCAGCTTGGGTGACAGAGTGAGACTCCATCTCAACAAAAAAAAAATCTAACTGAAGAACTAAGTTGATTTTTTATTTGCCATAAACCAA GCAAAAGTAAATGCAATAATTTCGAGATTTATGGTAAACAAATTTGAGGTATGGATAAATCTTTCACATATTTTTTATTGCTCTTTAGTA AAGAAAGGCACAAGAAAGAAAATATCCAGCTCTCTTGTGTTATCTCAGTGTGGCGACTGCAGAAAATTGACAATGCCTGCCTGTGTAAAT GTATGGCTTACTGTCAAAGCTTCATTCTTGGCTGCATGTTGAAAATGTGATTAAAGTTAATAGAGGAGATGAAATAAGTATTTGAGATTT TTTTCAATAACACTGAACTTCTGCCAACTTTCTCTATCCGCTACTGTAGGCTTGACAGGCTCATCAATCATTTGCTGGTACCTGGACTAA AAAGCGCACTTGCTGACACCAAGGCATGTTGGAATTTTCTTAATTCAGTGGATGGAAAAAGAAATACTTCCAAAAATATCCCACACATGA AAAGGGAGGGGAGCCTTAAATGAAAATTCCCTTTGTACCGTAGACACTTTTTGGAATGCGATTAATTGCCAACACATCATTGAACGAATG CTGTAACCAAGAAATTAAGATTGTGTGTGTGAAGGGAATATATTCTTAACTGTGGCTACCCAACTTGTATAGCAAAGATTTCTGATAGTT >In-frame_ENST00000540528_ENST00000397457_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(amino acids)=134AA_start in transcript=71_stop in transcript=475 MMDQARSAFSNLEKRGLREMRVLENLKNMIHETNEHTLPKCRDTMRDSLSQVLQRLQAANDSVCRLQQREQERKKIHSDHLVASEKQHML -------------------------------------------------------------- >In-frame_ENST00000540528_ENST00000543936_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(transcript)=1062nt_BP=107nt AGAGCGTCGGGATATCGGGTGGCGGCTCGGGACGGAGGACGCGCTAGTGTTCTTCTGTGTGGCAGTTCAGAATGATGGATCAAGCTAGAT CAGCATTCTCTAACTTGGAAAAACGTGGTCTTCGAGAAATGCGAGTTCTTGAAAATTTGAAGAACATGATCCATGAAACAAATGAACATA CTCTTCCCAAATGTAGAGACACAATGCGGGACAGCCTCAGCCAGGTTCTCCAGAGATTGCAAGCAGCTAATGACTCAGTCTGTAGACTCC AACAGAGGGAACAGGAACGAAAAAAGATTCATAGTGACCACTTAGTAGCTAGTGAGAAACAGCATATGCTCCAGTGGGACAACTTCATGA AGGAGCAACCCAACAAAAGGGCTGAAGTGGATGAAGAGCACAGAAAAGCCATGGAAAGGCTTAAAGAACAATATGCTGAGATGGAGAAGG ACCTAGCGAAATTTTCAACCTTTTAAGAACTTGAACCACAACAATCACAAACTAATGAGAAGATGTTCACCTCTCTCCTGAAAACTATTC CCACCAGACCGTTTAGCCTCTGCTTCAAGCTTAGCAATATATTCAGTGGCACTCTTATATCAGAAGAAAGAAGTTTCTACTGGCATTCTG ATTGGATATTTAAAGAAGGGTGCCACATTTTTCCAGCTTTAAGTGCCTATATATGATTATTTGAATGAAGAGGAGTAGGAAGGAAAATGG AATCAATATACTCTTTGTTAGTCAGAATTGATCATCTTTTCCATTGATTAGCTCAGAGAACTGTAGGTATAGACTTCTTAGAAAGATAAT TTCATTCATTTCTATACAGGGTTAACAATAGTTTATTATTGTGGCTTAATGGGAAGGTATAGAAGCTACCTGTCATAGCCTCCTTGGCTG TTGGAAGGATGTATAAAGTGTTACTGCATGAGTAATGTAGACAAAAAAAAAAGCCAGCTGTCCTTGGAGCAGAGATCACATTTCAGAGAG >In-frame_ENST00000540528_ENST00000543936_TCGA-G9-A9S7-01A_TFRC_chr3_195803935_-_BLOC1S5_chr6_8041501_length(amino acids)=134AA_start in transcript=71_stop in transcript=475 MMDQARSAFSNLEKRGLREMRVLENLKNMIHETNEHTLPKCRDTMRDSLSQVLQRLQAANDSVCRLQQREQERKKIHSDHLVASEKQHML -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for TFRC-BLOC1S5 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for TFRC-BLOC1S5 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for TFRC-BLOC1S5 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | TFRC | C0162316 | Iron deficiency anemia | 3 | CTD_human |
Hgene | TFRC | C0006142 | Malignant neoplasm of breast | 2 | CTD_human |
Hgene | TFRC | C0012715 | Iron Metabolism Disorders | 2 | CTD_human |
Hgene | TFRC | C0028754 | Obesity | 2 | CTD_human |
Hgene | TFRC | C0079487 | Helicobacter Infections | 2 | CTD_human |
Hgene | TFRC | C0678222 | Breast Carcinoma | 2 | CTD_human |
Hgene | TFRC | C1257931 | Mammary Neoplasms, Human | 2 | CTD_human |
Hgene | TFRC | C1458155 | Mammary Neoplasms | 2 | CTD_human |
Hgene | TFRC | C4704874 | Mammary Carcinoma, Human | 2 | CTD_human |
Hgene | TFRC | C0000786 | Spontaneous abortion | 1 | CTD_human |
Hgene | TFRC | C0000822 | Abortion, Tubal | 1 | CTD_human |
Hgene | TFRC | C0002875 | Cooley's anemia | 1 | CTD_human |
Hgene | TFRC | C0003756 | Arenaviridae Infections | 1 | CTD_human |
Hgene | TFRC | C0005283 | beta Thalassemia | 1 | CTD_human |
Hgene | TFRC | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Hgene | TFRC | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | TFRC | C0007621 | Neoplastic Cell Transformation | 1 | CTD_human |
Hgene | TFRC | C0009402 | Colorectal Carcinoma | 1 | CTD_human |
Hgene | TFRC | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | TFRC | C0017638 | Glioma | 1 | CTD_human |
Hgene | TFRC | C0019025 | Hemoglobin F Disease | 1 | CTD_human |
Hgene | TFRC | C0021368 | Inflammation | 1 | CTD_human |
Hgene | TFRC | C0023434 | Chronic Lymphocytic Leukemia | 1 | CTD_human |
Hgene | TFRC | C0024121 | Lung Neoplasms | 1 | CTD_human |
Hgene | TFRC | C0024302 | Reticulosarcoma | 1 | CTD_human |
Hgene | TFRC | C0024304 | Lymphoma, Mixed-Cell | 1 | CTD_human |
Hgene | TFRC | C0024305 | Lymphoma, Non-Hodgkin | 1 | CTD_human |
Hgene | TFRC | C0024306 | Lymphoma, Undifferentiated | 1 | CTD_human |
Hgene | TFRC | C0027055 | Myocardial Reperfusion Injury | 1 | CTD_human |
Hgene | TFRC | C0032460 | Polycystic Ovary Syndrome | 1 | CTD_human |
Hgene | TFRC | C0079740 | High Grade Lymphoma (neoplasm) | 1 | CTD_human |
Hgene | TFRC | C0079741 | Lymphoma, Intermediate-Grade | 1 | CTD_human |
Hgene | TFRC | C0079747 | Low Grade Lymphoma (neoplasm) | 1 | CTD_human |
Hgene | TFRC | C0079757 | Diffuse Mixed-Cell Lymphoma | 1 | CTD_human |
Hgene | TFRC | C0079770 | Lymphoma, Small Noncleaved-Cell | 1 | CTD_human |
Hgene | TFRC | C0085110 | Severe Combined Immunodeficiency | 1 | CTD_human |
Hgene | TFRC | C0085578 | Thalassemia Minor | 1 | CTD_human |
Hgene | TFRC | C0151744 | Myocardial Ischemia | 1 | CTD_human |
Hgene | TFRC | C0205671 | Infections, Arenavirus | 1 | CTD_human |
Hgene | TFRC | C0242379 | Malignant neoplasm of lung | 1 | CTD_human |
Hgene | TFRC | C0242583 | Bare Lymphocyte Syndrome | 1 | CTD_human |
Hgene | TFRC | C0259783 | mixed gliomas | 1 | CTD_human |
Hgene | TFRC | C0271979 | Thalassemia Intermedia | 1 | CTD_human |
Hgene | TFRC | C0494261 | Combined immunodeficiency | 1 | GENOMICS_ENGLAND |
Hgene | TFRC | C0555198 | Malignant Glioma | 1 | CTD_human |
Hgene | TFRC | C1136382 | Sclerocystic Ovaries | 1 | CTD_human |
Hgene | TFRC | C2700553 | Omenn Syndrome | 1 | CTD_human |
Hgene | TFRC | C3714542 | Lymphoma, Diffuse | 1 | CTD_human |
Hgene | TFRC | C3830362 | Early Pregnancy Loss | 1 | CTD_human |
Hgene | TFRC | C4225219 | IMMUNODEFICIENCY 46 | 1 | CTD_human;ORPHANET;UNIPROT |
Hgene | TFRC | C4552766 | Miscarriage | 1 | CTD_human |
Hgene | TFRC | C4721532 | Lymphoma, Non-Hodgkin, Familial | 1 | CTD_human |